Skip to main content


Figure 2 | Radiation Oncology

Figure 2

From: Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction

Figure 2

Kaplan-Meier survival curves for (a) overall survival; (b) local recurrence; and (c) distant recurrence (full dataset, n = 18). Analysis was performed at a median follow up of 952 days after start of RT (or 1065 days from the date of surgery). Overall survival was 88% at 1 year, 76% at 2 years and 58% at 3 years. Freedom from local recurrence was 88% at 1 year, 82% at 2 years and 82% at 3 years. Freedom from distant recurrence was 72% at 1 year, 67% at 2 years and 56% at 3 years.

Back to article page